[{"id":"aaaba290-6470-4f3a-a100-7ac1c47d32b8","acronym":"","url":"https://clinicaltrials.gov/study/NCT03493932","created_at":"2021-01-18T17:12:20.138Z","updated_at":"2024-07-02T16:35:36.303Z","phase":"Phase 1","brief_title":"Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade","source_id_and_acronym":"NCT03493932","lead_sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","biomarkers":" IFNG","pipe":" | ","alterations":" IFNG elevation","tags":["IFNG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IFNG elevation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Opdivo (nivolumab) • Yervoy (ipilimumab) • relatlimab (BMS-986016)"],"overall_status":"Completed","enrollment":" Enrollment 21","initiation":"Initiation: 09/24/2018","start_date":" 09/24/2018","primary_txt":" Primary completion: 04/21/2023","primary_completion_date":" 04/21/2023","study_txt":" Completion: 06/27/2023","study_completion_date":" 06/27/2023","last_update_posted":"2023-09-21"}]